We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-10 of 154

Comments to Draft Chicago Pharmaceutical Sales Representative License Rules Due April 2, 2017
  • Cooley LLP
  • USA
  • March 29 2017

As previously discussed, pharmaceutical sales representatives that conduct business in the City of Chicago will need to be licensed as of July 1, 2017

Illinois industry groups sign memorandum of cooperation with cChinese counterpart
  • Shook Hardy & Bacon LLP
  • USA
  • October 7 2011

According to Illinois Governor Pat Quinn (D), the Illinois Science & Technology Coalition and iBIO, a state-based life-sciences industry association, have entered a memorandum of understanding with the Shanghai Bio Pharmaceutics Association.

ANDA case stayed pending reexam
  • Holland & Knight LLP
  • USA
  • August 24 2011

Judge Dow used the Court's inherent power to grant plaintiff Genzyme's motion to stay the case pending the reexamination of Genzyme's patent related to its pharmaceutical drug Hectorol.

Fraudulent omission on prisoner pleading form results in dismissal with prejudice
  • Kelley Drye & Warren LLP
  • USA
  • February 15 2011

Joshua Hoskins had a number of complaints about the way he was treated in an Illinois prison.

Employee visits
  • Jones Day
  • USA
  • June 30 2010

An agreement by which a company promoted the sale of drugs manufactured by another created income tax nexus the Department determined that P.L. 86-272 did not apply to income generated by "distribution rights."

Omnicare v. UnitedHealth Group: important considerations for companies exchanging information in a merger or acquisition context
  • Hogan Lovells
  • USA
  • February 4 2009

On January 16, 2009, a federal district court in Chicago granted summary judgment to the defendants in Omnicare, Inc. v. UnitedHealth Group, Inc., et al, No. 1:06-cv-06235, a lawsuit involving information exchanged between competitors engaged in merger discussions and due diligence.

Ovation Pharmaceutical, Inc
  • Reed Smith LLP
  • USA
  • January 7 2009

On Dec. 16, 2008, the FTC filed a complaint against Ovation Pharmaceuticals, Inc. in the U.S. District Court for the District of Minnesota, alleging that the Illinois-based drug manufacturer illegally charged monopoly prices for its drug that is used to treat a life-threatening heart condition in premature infants, after purchasing the only similar medicine from a competitor in 2006.

John J. Richardson
  • Dinsmore & Shohl LLP